Pubblicazioni

The INCH trial - Induction chemotherapy in patients with bulky anal canal cancer: evaluation of the pilot phase

2021 - ANTICANCER RESEARCH

De Felice, F.; Fallarino, A.; Iafrate, F.; Maiuri, V.; Galloni, G.; Colonna, G. T.; De Pietro, R.; Chiarello, G.; Marchetti, C.; Bulzonetti, N.; Musio, D.; Tombolini, V.

Survival and toxicity of weekly cisplatin chemoradiotherapy versus three-weekly cisplatin chemoradiotherapy for head and neck cancer: a systematic review and meta-analysis endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

2021 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

De Felice, F.; Belgioia, L.; Alterio, D.; Bonomo, P.; Maddalo, M.; Paiar, F.; Denaro, N.; Corvo, R.; Merlotti, A.; Bossi, P.; Pappagallo, G. L.; D' Angelillo, R. M.; Magrini, S. M.; Arcangeli, S.

The importance of tumor stem cells in glioblastoma resistance to therapy

2021 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mattei, V.; Santilli, F.; Martellucci, S.; Monache, S. D.; Fabrizi, J.; Colapietro, A.; Angelucci, A.; Festuccia, C.

Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia

2021 - EXPERT OPINION ON DRUG SAFETY

Panzuto, F.; Magi, L.; Rinzivillo, M.

Endothelin-1 drives invadopodia and interaction with mesothelial cells through ILK

2021 - CELL REPORTS

Masi, I.; Caprara, V.; Spadaro, F.; Chellini, L.; Sestito, R.; Zancla, A.; Rainer, A.; Bagnato, A.; Rosano, L.

ImmuneOncology-tyrosine kinase inhibitors combination, sometimes less is more

2021 - INTERNATIONAL IMMUNOPHARMACOLOGY

Stellato, M.; Santini, D.